The insect cell-baculovirus expression vector system (IC-BEVS) has been an asset to produce biologics for over 30 years. With the current trend in biotechnology shifting toward process intensification and integration, developing intensified processes such as continuous production is crucial to hold this platform as a suitable alternative to others. However, the implementation of continuous production has been hindered by the lytic nature of this expression system and the process-detrimental virus passage effect. In this study, we implemented a multi-stage bioreactor setup for continuous production of influenza hemagglutinin-displaying virus-like particles (HA-VLPs) using IC-BEVS. A setup consisting of one Cell Growth Bioreactor simultaneously feeding non-infected insect cells to three parallel Production Bioreactors operated at different residence times (RT) (18, 36, and 54âh) was implemented; Production Bioreactors were continuously harvested. Two insect cell lines (neutral pH-adapted High Five and Sf9) and two recombinant baculovirus (rBAC) constructs (one that originates from a bacmid, rBAC(bacmid), and another of non-bacteria origin, rBAC(flashbac)) were tested. Combining rBAC(flashbac) with Sf9 cells was the most efficient approach, allowing consistent HA-VLPs titers (34â±â14 HA titer/mL) and rBAC titers (10(8)-10(9) pfu/mL) throughout the period of continuous operation (20 days). Cell growth kinetics and viability varied across RT, and higher RT was associated with increased expression of HA-VLPs, independent of the cell line and rBAC used; RT of 54âh allowed to maximize titers. The presence of particles resembling HA-VLPs was confirmed by transmission electron microscopy throughout the continuous operation. This work showcases the implementation of a process for continuous production of a promising class of biotherapeutics (i.e., VLPs), and paves the way for establishing continuous, integrated setups using the IC-BEVS expression system.
Continuous Production of Influenza VLPs Using IC-BEVS and Multi-Stage Bioreactors.
利用IC-BEVS和多级生物反应器连续生产流感病毒样颗粒
阅读:14
作者:Correia Ricardo, Zotler Taja, Ferraz Francisco, Fernandes Bárbara, Graça Miguel, Pijlman Gorben P, Alves Paula M, Roldão António
| 期刊: | Biotechnology and Bioengineering | 影响因子: | 3.600 |
| 时间: | 2025 | 起止号: | 2025 Apr;122(4):846-857 |
| doi: | 10.1002/bit.28925 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
